Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by KalVista Pharmaceuticals, Inc.
< Previous
1
2
3
4
Next >
KalVista Pharmaceuticals Presents Data on HAE Attacks in Patients Receiving Long-Term Prophylaxis at the Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2023 International Conference
October 24, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals to Present at Cantor Global Healthcare Conference
September 19, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Reports First Fiscal Quarter Results and Provides Operational Update
September 07, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals to Present HAE Attack Journey Data at 2023 HAEi Regional Conference EMEA
August 28, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 02, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Expands Senior Leadership Team with Appointment of Nicole Sweeny as Chief Commercial Officer
July 25, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Presents New HAE Attack Journey Data at 2023 US HAEA National Summit
July 24, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results
July 07, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 05, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Presents New Data at 2023 Meeting of the European Academy of Allergy and Clinical Immunology
June 12, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 05, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals to Present Data at the 2023 Meeting of the European Academy of Allergy and Clinical Immunology (EAACI)
June 02, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals to Present at Jefferies Global Healthcare Conference
May 31, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals to Present at Stifel 2023 Tailoring Genes: Genetic Medicines Day Virtual Conference
May 23, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Presents Data at 13th C1-inhibitor Deficiency & Angioedema Workshop
May 08, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 02, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals to Present Data at the 13th C1-inhibitor Deficiency & Angioedema Workshop
April 27, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals to Present at 22nd Annual Needham Virtual Healthcare Conference
April 12, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results
March 09, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Presents Data at American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
February 27, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals to Present Data at the 2023 American Academy of Allergy, Asthma & Immunology
February 16, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Provides Progress Updates on Sebetralstat Development
February 14, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Announces Publication of Sebetralstat Phase 2 Data in The Lancet
February 10, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Presents Data at Western Society of Allergy, Asthma & Immunology (WSAAI) 60th Annual Scientific Session
February 07, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals to Present at SVB Securities Global Biopharma Conference
February 03, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 02, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Announces Benjamin L. Palleiko Promoted to President
January 05, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 04, 2023
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
KalVista Pharmaceuticals Announces $58 Million Registered Direct Offering
December 27, 2022
From
KalVista Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALV
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.